2009
Multi-hit inhibition of circulating and cell-associated components of the toll-like receptor 4 pathway by oxidized phospholipids.
von Schlieffen E,
Oskolkova OV,
Schabbauer G,
Gruber F,
Blüml S,
Genest M,
Kadl A,
Marsik C,
Knapp S,
Chow J,
Leitinger N,
Binder BR,
Bochkov VN.
Arterioscler Thromb Vasc Biol, 2009 Mar; 29(3):356-62. Epub 2008 Dec 26.
2009
A biomedical adventurers’ guide to navigating between careers in academia and industry.
Superti-Furga G.
Nat Rev Mol Cell Biol, 2009 Dec;10(12):884-7.
2009
Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily.
Sillaber C,
Herrmann H,
Bennett K,
Rix U,
Baumgartner C,
Böhm A,
Herndlhofer S,
Tschachler E,
Superti-Furga G,
Jäger U,
Valent P.
Eur J Clin Invest, 2009 Dec;39(12): 1098-109.
2009
Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation.
Schwartz-Albiez R,
Monteiro RC,
Rodriguez M,
Binder CJ,
Shoenfeld Y.
Clin Exp Immunol, 2009 Dec;158 Suppl 1:43-50.
2009
Clonal analysis of deletions on chromosome 20q and JAK2-V617F in MPD suggests that del20q acts independently and is not one of the predisposing mutations for JAK2-V617F.
Schaub FX,
Jäger R,
Looser R,
Hao-Shen H,
Hermouet S,
Girodon F,
Tichelli A,
Gisslinger H,
Kralovics R,
Skoda RC.
Blood, 2009 Feb;113(9):2022-7.
2009
Target profiling of small molecules by chemical proteomics.
Rix U,
Superti-Furga G.
Nat Chem Biol, 2009 Sep;5(9):616-24.
2009
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profifiling and chemical proteomics in chronic myeloid leukemia cells.
Rix U,
Remsing Rix LL,
Terker AS,
Fernbach NV,
Hantschel O,
Planyavsky M,
Breitwieser FP,
Herrmann H,
Colinge J,
Bennett KL,
Augustin M,
Till JH,
Heinrich MC,
Valent P,
Superti-Furga G.
Leukemia, Epub 2009 Nov 5.
2009
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.
Remsing Rix LL,
Rix U,
Colinge J,
Hantschel O,
Bennett KL,
Stranzl T,
Müller A,
Baumgartner C,
Valent P,
Augustin M,
Till JH,
Superti-Furga G.
Leukemia, 2009 Mar;23(3):477-85.
2009
Activation of MDA5 requires higher-order RNA structures generated during virus infection.
Pichlmair A,
Schulz O,
Tan CP,
Rehwinkel J,
Kato H,
Takeuchi O,
Akira S,
Way M,
Schiavo G,
Reis e Sousa C.
J Virol, 2009 Oct;83(20):10761-9. Epub 2009 Aug 5.
2009
Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis.
Perne A,
Muellner MK,
Steinrueck M,
Craig- Mueller N,
Mayerhofer J,
Schwarzinger I,
Sloane M,
Uras IZ,
Hoermann G,
Nijman SM,
Mayerhofer M.
PLoS One, 2009 Dec 16; 4(12):e8292.
